[{"arm_notes": "", "treatment_id": null, "treatment_name": "Biological/Vaccine; Non-Stem Cell : Test Investigational Product:Part 1\u2022 CT-P59 80 mg/kg by single intravenous (IV) infusion over 90 minutes (\u00b115 minutes) with Standard of Care (SoC)\u2022 CT-P59 40 mg/kg by single IV infusion over 90 minutes (\u00b115 minutes) with SoCPart 2\u2022 CT-P59 40 mg/kg by single IV infusion over 60 minutes (\u00b115 minutes) with SoCReference Investigational Product:Part 1\u2022 Placebo matching in volume of CT-P59 80 mg/kg by single IV infusion over 90 minutes (\u00b115 minutes) with SoCPart 2\u2022 Placebo matching in volume of CT-P59 40 mg/kg by single IV infusion over 60 minutes (\u00b115 minutes) with SoC", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "40 mg/kg IV infusion over 90 minutes (\u00b1 15 minutes).", "treatment_id": 360, "treatment_name": "Ct-p59", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "80 mg/kg IV infusion over 90 minutes (\u00b1 15 minutes).", "treatment_id": 360, "treatment_name": "Ct-p59", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "IV infusion over 90 minutes (\u00b1 15 minutes).", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "40 mg/kg IV infusion over 60 minutes (\u00b1 15 minutes).", "treatment_id": 360, "treatment_name": "Ct-p59", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "IV infusion over 60 minutes (\u00b1 15 minutes).", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Drug : Test Investigational Product:Part 1\u2022 CT-P59 80 mg/kg by single intravenous (IV) infusion over 90 minutes (\u00b115 minutes) with Standard of Care (SoC)\u2022 CT-P59 40 mg/kg by single IV infusion over 90 minutes (\u00b115 minutes) with SoCPart 2\u2022 CT-P59 40 mg/kg by single IV infusion over 60 minutes (\u00b115 minutes) with SoCReference Investigational Product:Part 1\u2022 Placebo matching in volume of CT-P59 80 mg/kg by single IV infusion over 90 minutes (\u00b115 minutes) with SoCPart 2\u2022 Placebo matching in volume of CT-P59 40 mg/kg by single IV infusion over 60 minutes (\u00b115 minutes) with SoC", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Drug : TBD", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]